CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...